Wednesday, September 14, 2016

Allergan to buy experimental psoriasis drugmaker Vitae for $639 mln

NEW YORK, Sept 14 (Reuters) - Allergan Inc on

Wednesday said it would buy Vitae Pharmaceuticals,

which is testing an experimental drug to treat psoriasis and

other autoimmune disorders, for $639...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)